Showing 1 - 10 of 6,583
Persistent link: https://www.econbiz.de/10010465082
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and … keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external … knowledge, which helps improve their internal drug development capability. Our study examines the dynamic effects of licensing …
Persistent link: https://www.econbiz.de/10012219514
, has been a focus for these large MNC's scouting for licensing new drugs. This work analyses the licensing activities that …
Persistent link: https://www.econbiz.de/10012994958
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and … keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external … knowledge, which helps improve their internal drug development capability. Our study examines the dynamic effects of licensing …
Persistent link: https://www.econbiz.de/10012832198
There are several determinants that could have an effect on in-licensing decisions by a pharmaceutical or biotech firm …. This work studies over 200 licensing deals involving big pharma companies in the period (2011 – 2015) and identifies … different factors that could play a role in licensing deals, and classifies these determinants into direct determinants and …
Persistent link: https://www.econbiz.de/10014033016
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
In the last ten years, the pharmaceutical industry has experienced steep, unprecedented price increases. Pharmaceutical companies engage in R&D cooperations to cope with rocketing research and development (R&D) expenses.We study the impact of R&D cooperations on firms' research activities and...
Persistent link: https://www.econbiz.de/10012951300
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10013315639
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...
Persistent link: https://www.econbiz.de/10012064786
technologies in the markets, such as licensing, has not been adequately explored. To address this gap, we build on the real option … licensing …
Persistent link: https://www.econbiz.de/10014131939